Novartis fined $200k for eye promotion
By Megan Brodie 3 years ago | In Companies, Industry, Products- 3 years ago
31 March 2021 Bayer moved to defend its top-selling PBS-listed blockbuster eye drug EYLEA (aflibercept)…
This is subscriber-only content. Please login to continue reading.